Biomarkers for glioma immunotherapy: the next generation - Wikidata - thesis-toulmin - TriplyDB

Biomarkers for glioma immunotherapy: the next generation

Biomarkers for glioma immunotherapy: the next generation

http://www.wikidata.org/entity/Q26825496

about

Overview of current immunotherapeutic strategies for glioma Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies Prospects of immune checkpoint modulators in the treatment of glioblastoma Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.Diversity and divergence of the glioma-infiltrating T-cell receptor repertoire.Advances in Immunotherapy for Glioblastoma Multiforme.Circulating biomarkers for gliomas.An Update on the Role of Immunotherapy and Vaccine Strategies for Primary Brain Tumors.Immune Checkpoint Inhibitors in Gliomas.Immune infiltration of tumor microenvironment following immunotherapy for glioblastoma multiforme.

P2860

Q26776345-BCC0722E-0359-477F-A0C9-B9F1854F9FCC Q28072007-99BB944A-CAA7-4DF1-A780-FDA8199A1478 Q28081371-FEA45CE6-36C0-4F67-8B64-68631616581F Q31113520-B4B64C85-5492-4CBB-8F77-3B1856C46F06 Q37040756-92161585-6EBD-4E0D-83DB-E2A5DEF3107A Q37680966-6E5BFD0A-509C-4673-A926-F713958FFE84 Q38586617-5B239143-D680-4F4D-86AC-7BEB57237F9A Q38603909-BB0C62B1-8C10-4A26-B0CB-2F9534BCD66F Q38743793-5603A1D9-B9F5-4F93-B764-3FEE96F460A7 Q38864816-5AB89A72-F6FC-4128-B083-0288ACA07AE2

P2860

Biomarkers for glioma immunotherapy: the next generation

http://www.wikidata.org/entity/Q26825496

description

2015 nî lūn-bûn

@nan

2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Biomarkers for glioma immunotherapy: the next generation

@ast

Biomarkers for glioma immunotherapy: the next generation

@en

Biomarkers for glioma immunotherapy: the next generation

@nl

type

label

Biomarkers for glioma immunotherapy: the next generation

@ast

Biomarkers for glioma immunotherapy: the next generation

@en

Biomarkers for glioma immunotherapy: the next generation

@nl

prefLabel

Biomarkers for glioma immunotherapy: the next generation

@ast

Biomarkers for glioma immunotherapy: the next generation

@en

Biomarkers for glioma immunotherapy: the next generation

@nl

P1433

Q26825496-C51CA729-928B-45C6-86BA-528E2D5EFB4F

P1476

Q26825496-AF3875E9-E66A-4DD0-BDC6-F054BC7BB759

P2093

Q26825496-3AF92068-A972-4857-9F77-539B0BAE7F1E

Q26825496-8D0A076E-20D0-44AA-9187-52A8E02D9DF2

Q26825496-A0AE0132-4B92-43EE-BCDB-C48ADD9384D3

Q26825496-D1AEA1E1-0AA4-45BB-B2F5-B405BF90B4CF

Q26825496-EF2B08C9-CC7C-47F9-B0ED-D9F49762F32A

P2860

Q26825496-01796C0B-DA03-4AAF-B962-3CE7C78CB20A

Q26825496-02E3B7B7-AAF9-43E8-A711-8D92581A6941

Q26825496-051A17F5-BB96-4CDB-9D2B-C24E733C3385

Q26825496-07A6B546-0EF8-4121-BE89-66AF66C64B28

Q26825496-088EE28C-13F0-4C5C-94AF-153554122321

Q26825496-09570A12-47C7-4FB6-B692-1631B6BE31FD

Q26825496-0A54E94F-C3D8-4C7B-842C-7037821C9134

Q26825496-0AF07934-E18C-4683-B814-0A70A5592EEB

Q26825496-11529D87-61AB-4797-B9E7-D9F110130E72

Q26825496-12840990-605C-403C-8179-858E5AE791E3

P2888

Q26825496-A2FFD00D-384F-499D-9611-56590D5A4B69

P304

Q26825496-48641ABF-3CB0-4CBF-97B2-22CEEAEDD2B4

P31

Q26825496-11C26558-0892-4B67-AB06-D9DD50677776

P3181

Q26825496-4A380078-891D-46CB-8EAA-C4E59D5C2489

P356

Q26825496-2160A21C-6D2E-4A96-AA62-C11B0F466776

P407

Q26825496-9AE0EAA7-3718-4EE3-A11A-4276AA670735

P433

Q26825496-49DB1120-9C2F-48F3-A72F-1CB4D084F7FA

P478

Q26825496-AA22DAB2-1A35-4369-BEA4-1C04AF98D4AB

P577

Q26825496-A9245601-C789-479C-88B7-42E00BBE3105

P6179

Q26825496-70341199-351D-4563-809A-74C2FFE51531

P698

Q26825496-FCF6C6BC-950A-4FD4-8D24-B20315DF5F0F

P921

Q26825496-3A50F3BF-FE12-465E-8550-09111E8222BA

Q26825496-B3B12139-3898-4DAE-A500-F11E87C88C7F

P932

Q26825496-340D3517-E34D-420B-AC66-9F76C1F24BFB

P3181

P356

S11060-015-1746-9

P1433

Journal of Neuro-Oncology

P1476

Biomarkers for glioma immunotherapy: the next generation

@en

P2093

Jeffrey N. Bruce

http://www.w3.org/2001/XMLSchema#string

Jennifer S. Sims

http://www.w3.org/2001/XMLSchema#string

Justin A. Neira

http://www.w3.org/2001/XMLSchema#string

Peter Canoll

http://www.w3.org/2001/XMLSchema#string

Timothy H. Ung

http://www.w3.org/2001/XMLSchema#string

P2860

Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Viral immune evasion due to persistence of activated T cells without effector function

An integrated genomic analysis of human glioblastoma multiforme

IDH1 and IDH2 mutations in gliomas

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.

MGMT gene silencing and benefit from temozolomide in glioblastoma.

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

P2888

s11060-015-1746-9

P304

359-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3083064

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S11060-015-1746-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1002579319

http://www.w3.org/2001/XMLSchema#string

P698

25724916

http://www.w3.org/2001/XMLSchema#string

P921

P932

4498992

http://www.w3.org/2001/XMLSchema#string